Granulomatous cutaneous T-cell lymphoma in a patient with atage IVB of mycosis fungoides: a case report and literature review. [PDF]
Lin Z +9 more
europepmc +1 more source
Case Report: When syphilis imitates cancer: a case of misdiagnosed cutaneous T-cell lymphoma. [PDF]
Giordano U +5 more
europepmc +1 more source
Adipose‐Derived Mesenchymal Stem Cells: Isolation, Origin, Phenotype Applications, and Challenges
Bridging basic biology to clinical translation, this review systematically explores the in vivo origins and evolving isolation techniques of AD‐MSCs. We dissect their diverse phenotype applications orchestrated by immunometabolic reprogramming, mitochondrial transfer, and extracellular vesicles.
Ziyang Liu +7 more
wiley +1 more source
Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families. [PDF]
Buethe MG, Sy T, Eichenfield LF.
europepmc +1 more source
Regulatory T Cells in Health and Disease
Regulatory T cells (Tregs) arise through distinct developmental pathways and adapt to specialized tissue niches to maintain immune tolerance, barrier integrity, and metabolic homeostasis. In disease, Tregs undergo context‐dependent changes, ranging from functional insufficiency and lineage instability in autoimmune, inflammatory, cardiovascular, and ...
Mingyi Li +4 more
wiley +1 more source
Clinical Implications of the Skin Microbiota in the Therapy of Cutaneous T Cell Lymphoma: A Scoping Review. [PDF]
Czyz S +4 more
europepmc +1 more source
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang +15 more
wiley +1 more source
Barriers to timely diagnosis and treatment of cutaneous T-cell lymphoma in people with intellectual disabilities. [PDF]
Lapolla BA +8 more
europepmc +1 more source
This Phase I study evaluated unecritinib (TQ‐B3101) in pediatric patients with relapsed/refractory ALK+ anaplastic large‐cell lymphoma. Unecritinib showed a manageable safety profile without dose‐limiting toxicities and achieved remarkable efficacy, with a 100% overall response rate.
Suying Lu +10 more
wiley +1 more source
Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphoma. [PDF]
Özistanbullu D +18 more
europepmc +1 more source

